Cargando…
Examining neurodevelopmental problems in 15q11.2 (BP1‐BP2) copy number variation carriers at ages 9/12 and 18 in a Swedish twin sample
BACKGROUND: Several copy number variations (CNVs) are associated with increased risk for neurodevelopmental and psychiatric disorders. The CNV 15q11.2 (BP1‐BP2) deletion has been associated with learning difficulties, attention deficit hyperactivity disorder (ADHD), epilepsy, and brain morphology; h...
Autores principales: | Jonsson, Lina, Martin, Joanna, Lichtenstein, Paul, Magnusson, Patrik K. E., Lundström, Sebastian, Westberg, Lars, Tammimies, Kristiina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422071/ https://www.ncbi.nlm.nih.gov/pubmed/37156729 http://dx.doi.org/10.1002/mgg3.2191 |
Ejemplares similares
-
No signs of neurodegenerative effects in 15q11.2 BP1-BP2 copy number variant carriers in the UK Biobank
por: Boen, Rune, et al.
Publicado: (2023) -
Rare Pathogenic Copy Number Variation in the 16p11.2 (BP4–BP5) Region Associated with Neurodevelopmental and Neuropsychiatric Disorders: A Review of the Literature
por: Oliva-Teles, Natália, et al.
Publicado: (2020) -
Estimating the effect size of the 15Q11.2 BP1–BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice
por: Jønch, Aia Elise, et al.
Publicado: (2019) -
The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review
por: Cox, Devin M., et al.
Publicado: (2015) -
Should We Report 15q11.2 BP1-BP2 Deletions and Duplications in the Prenatal Setting?
por: Maya, Idit, et al.
Publicado: (2020)